Press release
Impact Of Increasing Cancer And Cardiovascular Disease Prevalence On The Growth Of The Generic Injectable Market: A Key Factor Shaping the Future of the Generic Injectables Market in 2025
What combination of drivers is leading to accelerated growth in the generic injectables market?
The escalating occurrence of cancer and cardiovascular ailments is set to fuel an increase in the generic injectable market in the future. The term cardiovascular diseases encompasses various disorders affecting the heart and blood vessels, while cancer is defined as a disease where the body's cells multiply uncontrollably and spread elsewhere in the body. Generic injectables have a crucial role in treating cancer and cardiac diseases as they offer similar pharmaceutical equivalence or bioequivalence to brand drugs. They also increase the availability and accessibility of drugs, making treatment more affordable. The World Health Organization reported in September 2022, 41 million deaths, accounting for 74% of deaths caused by noncommunicable diseases (NCDs) or chronic diseases worldwide each year. Among these, 17.9 million were due to cardiovascular diseases, 9.3 million were due to cancer, 4.1 million from chronic respiratory diseases, and 2.0 million were due to diabetes. Consequently, the increasing incidence of cancer and cardiovascular diseases is stimulating the expansion of the generic injectable market.
Get Your Generic Injectables Market Report Here:
https://www.thebusinessresearchcompany.com/report/generic-injectables-global-market-report
What is the projected compound annual growth rate (CAGR) of the generic injectables market from 2025 to 2034, and what factors influence it?
In the past few years, the size of the generic injectables market has seen a swift expansion. It is projected to increase from $124.61 billion in 2024 to $143.13 billion in 2025, presenting a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this growth during the historic period include cost-effectiveness, expiry of patents, initiatives regarding healthcare access, competition in the market, and prevailing global pharmaceutical trends.
In the forthcoming years, the generic injectables market size is anticipated to undergo swift expansion. It is projected to garner a valuation of "$238.43 billion by 2029, with a compound annual growth rate (CAGR) of 13.6%. The expansion during the forecast period is owed to factors such as a growing elderly population, strategic collaborations, regulatory modifications, heightened healthcare awareness, and market innovation. During the forecast period, significant trends include an emphasis on quality and regulatory adherence, utilization of the 505 (b) (2) regulatory pathway, introduction of unique drug delivery tech, collaboration and partnerships within the sector, and an elevated concentration on specialty injectable treatments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
How are the latest trends influencing the growth of the generic injectables market?
The emergence of product innovations is a significant trend being observed in the generic injectables market. To maintain their standing in this market, major corporations are progressing with their generic injectables. In a specific example from April 2022, Dr. Reddy's Laboratories, a pharmaceutical company based in India, released its Treprostinil Injection to the U.S. market. This medication is a generic equivalent to Remodulin (treprostinil) Injection, which has received approval from the U. S. Food and Drug Administration (USFDA), a U.S.-based entity. Its application is designed for patients in need of a transition from epoprostenol to decrease the speed of clinical degradation.
What are the major segments of the generic injectables market and their role in driving growth?
The generic injectables market covered in this report is segmented -
1) By Product Type: Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Other Products
2) By Container Type: Vials, Ampoules, Premix, Prefilled Syringes, Other Containers
3) By Route Of Administration: Intravenous, Intramuscular, Subcutaneous, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores
5) By Application: Oncology, Diabetes , Infectious Diseases , Blood Disorders , Musculoskeletal Disorders , Hormonal Disorders , Pain Management , CNS Diseases , Cardiovascular Diseases
Subsegments:
1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies, Other Types Of Monoclonal Antibodies
2) By Cytokines: Interferons, Interleukins, Tumor Necrosis Factor (TNF) Inhibitors
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin
4) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
5) By Other Products: Hormones, Peptides, Enzymes
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10776
Which regions are key players in the growth of the generic injectables market?
North America was the largest region in the generic injectable market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generic injectables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the generic injectables market?
Major companies operating in the generic injectables market include Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Merck & Co. Inc., Biocon Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Samsung Biologics Co. Ltd., Piramal Pharma Limited, Bristol-Myers Squibb Company, Pfizer Inc., Hikma Pharmaceuticals PLC, Par Pharmaceutical, Pharmascience Inc., SAGENT Pharmaceuticals, AmerisourceBergen Corporation, Hospira Inc., Sandoz International GmbH, Singota Solutions Inc., MVASI Bevacizumab-awwb Syringes, Mylan N.V., Sun Pharmaceutical Industries Ltd., Endo International plc, Akorn Pharmaceuticals Inc., Wockhardt Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
What Is Covered In The Generic Injectables Global Market Report?
• Market Size Forecast: Examine the generic injectables market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the generic injectables market for a structured understanding.
• Key Players Overview: Analyze major players in the generic injectables market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the generic injectables market.
• Segment Contributions: Evaluate how different segments drive overall growth in the generic injectables market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the generic injectables market.
• Industry Challenges: Identify potential risks and obstacles affecting the generic injectables market.
• Competitive Landscape: Review strategic developments in the generic injectables market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
The escalating occurrence of cancer and cardiovascular ailments is set to fuel an increase in the generic injectable market in the future. The term cardiovascular diseases encompasses various disorders affecting the heart and blood vessels, while cancer is defined as a disease where the body's cells multiply uncontrollably and spread elsewhere in the body. Generic injectables have a crucial role in treating cancer and cardiac diseases as they offer similar pharmaceutical equivalence or bioequivalence to brand drugs. They also increase the availability and accessibility of drugs, making treatment more affordable. The World Health Organization reported in September 2022, 41 million deaths, accounting for 74% of deaths caused by noncommunicable diseases (NCDs) or chronic diseases worldwide each year. Among these, 17.9 million were due to cardiovascular diseases, 9.3 million were due to cancer, 4.1 million from chronic respiratory diseases, and 2.0 million were due to diabetes. Consequently, the increasing incidence of cancer and cardiovascular diseases is stimulating the expansion of the generic injectable market.
Get Your Generic Injectables Market Report Here:
https://www.thebusinessresearchcompany.com/report/generic-injectables-global-market-report
What is the projected compound annual growth rate (CAGR) of the generic injectables market from 2025 to 2034, and what factors influence it?
In the past few years, the size of the generic injectables market has seen a swift expansion. It is projected to increase from $124.61 billion in 2024 to $143.13 billion in 2025, presenting a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this growth during the historic period include cost-effectiveness, expiry of patents, initiatives regarding healthcare access, competition in the market, and prevailing global pharmaceutical trends.
In the forthcoming years, the generic injectables market size is anticipated to undergo swift expansion. It is projected to garner a valuation of "$238.43 billion by 2029, with a compound annual growth rate (CAGR) of 13.6%. The expansion during the forecast period is owed to factors such as a growing elderly population, strategic collaborations, regulatory modifications, heightened healthcare awareness, and market innovation. During the forecast period, significant trends include an emphasis on quality and regulatory adherence, utilization of the 505 (b) (2) regulatory pathway, introduction of unique drug delivery tech, collaboration and partnerships within the sector, and an elevated concentration on specialty injectable treatments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
How are the latest trends influencing the growth of the generic injectables market?
The emergence of product innovations is a significant trend being observed in the generic injectables market. To maintain their standing in this market, major corporations are progressing with their generic injectables. In a specific example from April 2022, Dr. Reddy's Laboratories, a pharmaceutical company based in India, released its Treprostinil Injection to the U.S. market. This medication is a generic equivalent to Remodulin (treprostinil) Injection, which has received approval from the U. S. Food and Drug Administration (USFDA), a U.S.-based entity. Its application is designed for patients in need of a transition from epoprostenol to decrease the speed of clinical degradation.
What are the major segments of the generic injectables market and their role in driving growth?
The generic injectables market covered in this report is segmented -
1) By Product Type: Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Other Products
2) By Container Type: Vials, Ampoules, Premix, Prefilled Syringes, Other Containers
3) By Route Of Administration: Intravenous, Intramuscular, Subcutaneous, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores
5) By Application: Oncology, Diabetes , Infectious Diseases , Blood Disorders , Musculoskeletal Disorders , Hormonal Disorders , Pain Management , CNS Diseases , Cardiovascular Diseases
Subsegments:
1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies, Other Types Of Monoclonal Antibodies
2) By Cytokines: Interferons, Interleukins, Tumor Necrosis Factor (TNF) Inhibitors
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin
4) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
5) By Other Products: Hormones, Peptides, Enzymes
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10776
Which regions are key players in the growth of the generic injectables market?
North America was the largest region in the generic injectable market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generic injectables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the generic injectables market?
Major companies operating in the generic injectables market include Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Merck & Co. Inc., Biocon Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Samsung Biologics Co. Ltd., Piramal Pharma Limited, Bristol-Myers Squibb Company, Pfizer Inc., Hikma Pharmaceuticals PLC, Par Pharmaceutical, Pharmascience Inc., SAGENT Pharmaceuticals, AmerisourceBergen Corporation, Hospira Inc., Sandoz International GmbH, Singota Solutions Inc., MVASI Bevacizumab-awwb Syringes, Mylan N.V., Sun Pharmaceutical Industries Ltd., Endo International plc, Akorn Pharmaceuticals Inc., Wockhardt Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
What Is Covered In The Generic Injectables Global Market Report?
• Market Size Forecast: Examine the generic injectables market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the generic injectables market for a structured understanding.
• Key Players Overview: Analyze major players in the generic injectables market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the generic injectables market.
• Segment Contributions: Evaluate how different segments drive overall growth in the generic injectables market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the generic injectables market.
• Industry Challenges: Identify potential risks and obstacles affecting the generic injectables market.
• Competitive Landscape: Review strategic developments in the generic injectables market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
